---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-027196"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2025-12-11T23:59:59+00:00"
generated_at: "2026-05-16T13:36:27.797877+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Enveric shareholders approve 50x increase in authorized shares and reverse split authority

## Summary
- Approved increase in authorized common shares from 100M to 5B (50x) at board discretion.
- Authorized reverse stock split at ratio between 1:5 and 1:15, with board to set exact ratio.
- Issuance proposal to issue shares underlying warrants for Nasdaq Rule 5635 compliance passed.
- Adjournment proposal rendered moot as quorum was achieved; all three proposals passed.

## SEC filing metadata
- accession: 0001493152-25-027196
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2025-12-11T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315225027196/0001493152-25-027196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315225027196/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-027196
- JSON: https://secwatch.observer/filing/0001493152-25-027196.json
- Plain text: https://secwatch.observer/filing/0001493152-25-027196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.